- In a 155-page lawsuit, Cleveland leaders accused numerous retail pharmacies, drugmakers and pharmacy benefit managers of hiking insulin prices that they said cost the city millions of dollars, according to court documents. The defendants are drugmakers Eli Lilly, Novo Nordisk and Sanofi-Aventis; PBM Evernorth Health; Express Scripts and its subsidiaries Medco Health Solutions and Esi Mail Pharmacy Services; CVS Health and CVS Caremark; and UnitedHealth Group and its businesses Optum, OptumRx and OptumInsight.
- Amar Desai, MD, announced he had been named CEO of Optum Health and will oversee the organization’s 135,000 team members.
- Optum’s revenues and earnings both grew by double digits in the second quarter.
- Disruptors such as CVS Health and Optum are buying home health companies to grab a share of the $265 billion of Medicare services that are expected to move to the home by 2025.
- EHR vendor Epic Systems, Nashville, Tenn.-based HCA Healthcare and Optum pledged their support for the Sequoia Project’s new health data initiative that aims to make healthcare data more useful.
- Kristi Henderson, DNP, left her executive roles at Optum to helm Confluent Health, a family of physical and occupational therapy companies based in Louisville, Ky.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
